MediciNova nabs new U.S. patent for ibudilast in multiple sclerosis



MediciNova nabs new U.S. patent for ibudilast in multiple sclerosis



READ SOURCE

READ  FPI investment limit on govt papers remain unchanged: RBI

LEAVE A REPLY

Please enter your comment!
Please enter your name here